Medicare Enrolled
Dr. David Rahni, M.D
Internal Medicine · West Orange, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rahni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rahni?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rahni
Dr. David Rahni is an internal medicine specialist in West Orange, NJ, with 16 years of NPI registration. Based on federal Medicare data, Dr. Rahni performed 1,942 Medicare services across 1,371 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rahni received a total of $13,259 from 58 pharmaceutical and/or device companies across 1022 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rahni is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 23% volume in NJ
$13,259 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,942
Medicare services
Top 23% in NJ for internal medicine
1,371
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~121 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
496 | $73 | $509 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
459 | $68 | $477 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
176 | $102 | $684 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
136 | $223 | $3,094 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
126 | $68 | $2,649 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
101 | $89 | $729 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
81 | $90 | $2,993 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
58 | $75 | $509 |
| Ultrasound-guided esophageal needle biopsy A procedure using a flexible endoscope with ultrasound to guide a needle for sampling tissue from the esophagus. |
38 | $188 | $1,573 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
31 | $87 | $1,977 |
| Endoscopic ultrasound of esophagus, stomach, or small bowel An ultrasound exam of the esophagus, stomach, and/or upper small bowel performed using a flexible endoscope inserted through the mouth. |
31 | $135 | $1,325 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
30 | $184 | $2,191 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $88 | $736 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
28 | $105 | $736 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
25 | $48 | $312 |
| Endoscopic removal of bile or pancreatic duct stone A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts. |
24 | $227 | $2,459 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
20 | $121 | $2,016 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
16 | $200 | $2,302 |
| Endoscopic incision of pancreatic outlet A procedure where a flexible endoscope is used to make an incision in the pancreatic outlet. |
13 | $72 | $2,533 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
13 | $55 | $518 |
| Endoscopic control of upper GI bleeding A flexible endoscope is used to locate and stop bleeding in the esophagus, stomach, or upper small intestine. |
11 | $158 | $4,684 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,259
Total received (2018-2024)
Avg $1,894/year across 7 years
Top 5% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
1,022
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,199 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$60 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,545
2023
$2,658
2022
$3,288
2021
$1,500
2020
$798
2019
$1,185
2018
$1,285
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$587
ABBVIE INC.
$402
Celgene Corporation
$350
Janssen Biotech, Inc.
$282
Fresenius Kabi USA, LLC
$133
Takeda Pharmaceuticals U.S.A., Inc.
$104
Lilly USA, LLC
$82
Intra-Sana Laboratories
$73
IRONWOOD PHARMACEUTICALS, INC
$71
Ardelyx, Inc.
$67
Boston Scientific Corporation
$58
Intercept Pharmaceuticals, Inc.
$35
Regeneron Healthcare Solutions, Inc.
$34
Tempus AI, Inc
$30
VIVUS LLC
$29
Gilead Sciences, Inc.
$29
Braintree Laboratories, Inc.
$25
Medtronic, Inc.
$21
GENZYME CORPORATION
$19
Biocon Biologics Inc
$19
Exact Sciences Corporation
$17
Madrigal Pharmaceuticals
$17
Ipsen Biopharmaceuticals, Inc
$17
CapsoVision, Inc.
$16
Celltrion USA Inc.
$13
AIMMUNE THERAPEUTICS, INC.
$13
Top 3 companies account for 52.6% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$3,036
ABBVIE INC.
$1,242
Janssen Biotech, Inc.
$1,073
Celgene Corporation
$1,058
Boston Scientific Corporation
$822
Takeda Pharmaceuticals U.S.A., Inc.
$557
Ironwood Pharmaceuticals, Inc
$393
AbbVie, Inc.
$362
AbbVie Inc.
$323
Evoke Pharma, Inc.
$319
Gilead Sciences, Inc.
$317
PFIZER INC.
$291
Braintree Laboratories, Inc.
$263
Daiichi Sankyo Inc.
$250
E.R. Squibb & Sons, L.L.C.
$244
RedHill Biopharma Inc.
$227
Merck Sharp & Dohme Corporation
$211
Ardelyx, Inc.
$196
Fresenius Kabi USA, LLC
$182
Ferring Pharmaceuticals Inc.
$153
Olympus America Inc.
$151
Intercept Pharmaceuticals, Inc.
$131
IRONWOOD PHARMACEUTICALS, INC
$111
Merck Sharp & Dohme LLC
$108
Allergan Inc.
$101
Lilly USA, LLC
$100
INTERCEPT PHARMACEUTICALS, INC.
$85
VIVUS LLC
$73
Intra-Sana Laboratories
$73
QOL Medical, LLC
$70
Nestle HealthCare Nutrition Inc.
$68
Celltrion USA Inc.
$60
Synergy Pharmaceuticals Inc
$55
Regeneron Healthcare Solutions, Inc.
$47
VIVUS, Inc.
$47
BOSTON SCIENTIFIC CORPORATION
$43
Medtronic, Inc.
$35
GENZYME CORPORATION
$35
Tempus AI, Inc
$30
CONMED Corporation
$29
EVOKE PHARMA, INC.
$29
Ambu Inc.
$24
Biocon Biologics Inc
$19
Exact Sciences Corporation
$17
Madrigal Pharmaceuticals
$17
Blueprint Medicines Corporation
$17
Ipsen Biopharmaceuticals, Inc
$17
NESTLE HEALTHCARE NUTRITION INC.
$16
CapsoVision, Inc.
$16
Micro-tech Endoscopy USA, Inc.
$16
INTRA-SANA LABORATORIES
$14
Shire North American Group Inc
$14
W. L. Gore & Associates, Inc.
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
AIMMUNE THERAPEUTICS, INC.
$13
Echosens North America, Inc.
$11
Alfasigma USA, Inc.
$11
UCB, Inc.
$11
Top 3 companies account for 40.4% of all-time payments
Associated products mentioned in payments ›
AGILE · APRISO · AYVAKIT · Acquire · Advanix Biliary · Aemcolo · Amitiza · CIMZIA · CLENPIQ · CONMED HEMOSTASIS · CREON · CYLTEZO · CapsoCam Plus · Cimzia · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · Dexilant · ENDOFLIP · ENTYVIO · EOHILIA · EXALT · EXALT Model D · Endocuff Vision · Entyvio · FibroScan · GATTEX · GENERAL ENDOCHOICE · GI Genius · GIMOTI · GORE CARDIOFORM Septal Occluder · General - Hemostasis · General - Metal Stents - G.I. · HANAROSTENT Esophagus TTS(CCC) · HUMIRA · Hulio · Humira · Hydratome RX 44 · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · IQIRVO · Koala · LINZESS · Lesion Hunter · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · Mavyret · Motegrity · Movantik · NOXAFIL · OCALIVA · OMVOH · ORISE · Olympus EndoTherapy Accessories · OrcaPod · PANCREAZE · PLENVU · QSYMIA · Qsymia · REBYOTA · RELTONE 200 MG · REMICADE · RESMETIROM · RESOLUTION CLIP · RINVOQ · Resolution 360 Clip · SIMPONI ARIA · SKYRIZI · SPYGLASS · STELARA · SUCRAID · SUFLAVE · SUPREP · SUTAB · SpyGlass · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · UCERIS TABLETS · VIBERZI · XELJANZ · XIFAXAN · YUFLYMA · ZENPEP · ZEPATIER · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for internal medicine in NJ.
Geographic Context
Internal medicine physicians within 10 mi
9,860
Per 100K population
1154.4
County median income
$76,712
Nearest hospital
HACKENSACK MERIDIAN MOUNTAINSIDE MEDICAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rahni is a clinical cardiology specialist, with above-average Medicare volume (top 23% in NJ), with low-engagement industry engagement in the top 5% of NJ peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rahni experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Rahni performed 496 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rahni receive payments from pharmaceutical companies?
Yes. Dr. Rahni received a total of $13,259 from 58 companies across 1,022 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rahni's costs compare to other internal medicine physicians in West Orange?
Dr. Rahni's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rahni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in West Orange
Browse internal medicine physicians in West Orange ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology